Pharmafile Logo
Pharmafocus logo
Advanced Search

drug

Showing 15 posts of 15 posts found.

8266471202_63a8f743a9_b_0

Merck, Novartis and Allergan to raise US drug prices, following most of drug industry

January 6, 2020
Manufacturing and Production Allgeran, Big Pharma, Merck, Novartis, drug, drug prices

Following most of the large pharmaceutical companies, Merck, Novartis and Allergan have chosen to raise their drug prices. Novartis is …

News
amgen_hq

Amgen slashes price of cholesterol drug Repatha by 60%

October 25, 2018
Sales and Marketing Repatha, cholestrol, drug, medicine, pricing

American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%. The …

News

Roche’s flu drug speeds up recovery in Phase III trial

October 4, 2018
Research and Development Roche, drug, flu, pharma, recovery

Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …

News
5204602349_c87b204860_z

FDA rejects Sunovion’s ADHD drug dasotraline

September 3, 2018
Sales and Marketing ADHD, FDA, dasotraline, drug, sunovion

The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment …

News
26022266362_1bf5a2747e_z

Researchers develop anti-nicotine addiction drugs

August 28, 2018
Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …

News
clinical_trial_3

Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug

June 22, 2016
Research and Development FDA, drug, huntington's disease, wave life sciences

Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …

News

Sun Pharma to partner with ICGEB to develop novel Dengue treatment

May 4, 2016
Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical

Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …

News
afinitor_combo-front

Novartis drug Afinitor significantly reduces seizures in TSC patients

April 21, 2016
Research and Development Afinitor, Novartis, Tuberous Sclerosis Complex, drug, seizure, seizures, tsc

Novartis (SIX: NOVN) has announced the results from a Phase III clinical trial which shows that Afinitor (everolimus) significantly reduced …

News
cancer_cells

Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer

April 15, 2016
Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university

Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …

News
jj_sign_on_wall

Tesaro shares rise as J&J buys rights to prostate cancer drug for $85 million

April 6, 2016
Business Services, Research and Development, Sales and Marketing Cancer, J&J, JJ, M&A, MA, Tesaro, drug, licence agreement, research

Shares in oncology-focussed Tesaro Inc (Nasdaq: TSRO) jumped Wednesday after the company said pharma major Johnson & Johnson (NYSE: JNJ) …

News
bayercross3

FDA approves Bayer haemophilia A drug Kovaltry

March 17, 2016
Research and Development, Sales and Marketing Bayer, FDA, approval, drug, drug approval, haemophilia, haemophilia a, kovaltry, viii compound

Bayer (ETR:BAYN) has received approval from the US Food and Drug Administration (FDA) for Kovaltry (octocog alfa), an unmodified, full-length …

News

FDA launches drug shortages app

March 6, 2015
Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages

The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …

News
LaMattina image

Drug prices defy gravity – until patent expiry

June 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research

How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …

Feature
LaMattina image

John LaMattina: FDA tries to disavow role in higher hurdles for new drugs

July 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug

As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …

Feature

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024